Findings from a large study indicate that 25-hydroxyvitamin D levels during foetal life are not linked to childhood bone health independently of childhood vitamin D exposure.
A study details the clinical characteristics of patients who have autosomal dominant short stature caused by heterozygous mutations in the aggrecan gene.
The results of a meta-analysis support a modest positive effect of recombinant human growth hormone on the height of children with achondroplasia.
Randomised trial findings suggest that the target level of dietary vitamin D intake may not be sufficient to maintain children’s circulating 25-hydroxyvitamin D concentration at a desired level.
The occurrence of 91 confirmed or probable hypocalcaemic seizures in children with vitamin D deficiency over a 2-year period in the UK highlights a failure to promote appropriate supplementation.